News and Events
Celebrating CCR Careers: Alan Rein, Ph.D.
Alan Rein, Ph.D., is a known expert in the field of viral assembly, particularly in retroviruses like the human immunodeficiency virus (HIV). After an extensive career studying molecular mechanisms of retroviral replication and pathogenesis, he has announced his retirement.
Read MoreBiology & Biophysics of the Nucleus Symposium - October 20-21, 2022
The mission of the Center of Excellence in Chromosome Biology (CECB) is to achieve a comprehensive understanding of the mechanisms involved in chromosome function, how aberrations in chromosomes and chromatin lead to disease and how these defects can be corrected.
Towards achieving the mission, the Biology & Biophysics of the Nucleus Symposium brings together scientists in the fields of chromatin and chromosome biology, with the focus on stem cells, cell development, aging and cancer.
We hope this symposium offers you an opportunity to learn more about the current status of chromosome structure and function in development and disease, to share your research and to discuss the use and implications of these advances for clinical applications.
Organized by: Shalini Oberdoerffer, Ph.D., Gordon Hager, Ph.D., and Dave Levens, M.D., Ph.D.
Read MoreClinical trial researching therapy for bile duct cancer
A clinical trial led by Jonathan Hernandez, M.D., Investigator in the Surgical Oncology Program, is researching a combination of immunotherapy and chemotherapy for liver-only cholangiocarcinoma.
Read MoreCelebrating Hispanic Heritage Month: A Conversation with Cecilia Monge, M.D., M.P.H., F.A.C.P.
Cecilia Monge, M.D., M.P.H., F.A.C.P., is an Assistant Research Physician in the Thoracic and GI Malignancies Branch. She is from Costa Rica where she completed medical school and worked for ten years. For this Hispanic Heritage Month Q&A, she tells us about her interests in health disparities research, her experience working in a developing country and what makes a good mentor.
Read MoreAligned Blog: Celebrating Hispanic Heritage!
Happy Hispanic Heritage Month! For this edition of Aligned, I thought I would celebrate some of my Latino/a/x friends and colleagues here at the Center for Cancer Research. I asked each of them to “Tell me why your Hispanic Heritage is important to you (and something you love about it).” I hope they inspire you to learn more about the many ways in which we have all benefitted from their Hispanic Heritage.
Read MoreCelebrating Hispanic Heritage Month: A Conversation with Kylynda Bauer, Ph.D.
Kylynda Bauer, Ph.D., is an iCURE scholar in the Thoracic and GI Malignancies Branch. In this Hispanic Heritage Month Q&A, she speaks to us about the influences of her diverse cultural background, the importance of reaching out to others and what she enjoys about the iCURE program.
Read MoreClinical trial evaluates drug combination for inoperable neuroendocrine tumors
Neuroendocrine tumors occur in cells of the endocrine and nervous systems. A combined phase I/II clinical trial at the NIH Clinical Center evaluates the effectiveness of a combination of two agents that may work in complementary ways to target inoperable or metastatic neuroendocrine tumors.
Read MoreClinical trial researching T-cell therapy for sarcoma
John W. Glod, M.D., Ph.D., Associate Research Physician in the Pediatric Oncology Branch, is leading NCI’s participation in a clinical trial researching T-cell therapy for sarcomas.
Read MoreT-cell imbalance can impact immunotherapy outcomes
The rapid growth of a patient’s cancer following immune checkpoint inhibitor therapy, known as hyperprogressive disease, is an unexpected treatment outcome that is challenging to predict or study. New results show that a T-cell imbalance in the tumor microenvironment can trigger the condition.
Read MoreMapping cells’ mechanical properties for insight into metastasis
A new approach allows researchers to investigate cells’ mechanical properties in tissue-like environments.
Read MoreClinical trial researching therapy for tumors that have spread to the lining of the abdomen
A clinical trial led by Andrew M. Blakely, M.D., Assistant Research Physician in the Surgical Oncology Program, is researching a combination drug therapy for peritoneal carcinomatosis, a condition in which tumors have spread along the lining of the abdomen from the appendix, colon, ovary or mesothelioma.
Read More